Thursday, July 3, 2025
HomeIndustriesHealthcare

Healthcare

Fusion Pharmaceuticals Announces Nomination of First Targeted Alpha Therapy Candidate in Collaboration with AstraZeneca

Fusion Pharmaceuticals Inc., a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines, announced nomination of the first targeted alpha therapy (TAT)...

As Omicron Surges, Kroger Health Reaches Important Milestone in Virus Response

Kroger Health, the healthcare division of The Kroger Co. Family of Companies, achieved the administration of its 10 millionth dose of COVID-19 vaccine. This...

Takeda to Acquire Adaptate Biotherapeutics to Develop Novel Gamma Delta (γδ) T Cell Engager Therapies Targeting Solid Tumors

Takeda Pharmaceutical Company Limited (“Takeda”) announced the exercise of its option to acquire Adaptate Biotherapeutics (“Adaptate”), a UK company focused on developing antibody-based therapeutics...

Nanoscope Awarded Key U.S. Patent Protecting its Multi-Characteristic Opsin Gene Therapy Platform For Reversing Blindness

Nanoscope Therapeutics Inc, a clinical-stage biotechnology company developing optogenetic gene therapies for retinal degenerative diseases, today announced that Nanoscope has been awarded U.S. patent...

BioAtla Announces Clinical Collaboration with Bristol Myers Squibb for Treatment of Solid Tumors

BioAtla, Inc., a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics, announced that it has entered into...
0FansLike
0FollowersFollow
spot_img

Hot Topics